KalVista Pharmaceuticals
Mitchell Childs graduated with a Master's Degree in Chemistry from the University of Southampton in 2016. Mitchell has worked as a Placement Student at KalVista Pharmaceuticals Ltd from July 2015 to December 2015, and currently holds the position of Senior Scientist at KalVista Pharmaceuticals, Inc. since August 2016.
This person is not in any offices
KalVista Pharmaceuticals
2 followers
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....